欧洲组织工程市场预测至 2028 年 – COVID-19 影响和区域分析 – 按材料类型(合成材料、生物衍生材料等)和应用(骨科、肌肉骨骼和脊柱、神经病学、心脏病学和血管、皮肤)和外皮、泌尿科、胃肠道和妇科、癌症等)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 133    |    Report Code: TIPRE00013292    |    Category: Life Sciences

Europe Tissue Engineering Market

欧洲组织工程市场预计将从2021年的38.5949亿美元增长到2028年的85.207亿美元;预计2021年至2028年复合年增长率为12.0%。

慢性病发病率不断上升,外伤和道路事故数量不断增加,推动了对先进治疗程序的需求,包括组织工程。道路交通事故是全世界主要的死亡原因之一,因为它们会造成骨骼和器官的严重伤害。根据世界卫生组织 (WHO) 的数据,每年约有 20—5000 万人在道路事故中受伤。组织工程为修复受损组织提供了手术重建、移植和机械设备指导的替代方案。组织工程市场的主要驱动力是对有效再生疗法的持续需求,以治疗越来越多的糖尿病、肥胖症和其他由生活方式改变引起的疾病。老年人口激增;外伤病例数量不断增加。脊髓损伤 (SCI) 可能会导致脊髓受损,从而暂时或永久改变其功能。在全球范围内,创伤性和非创伤性 SCI 的平均患病率估计为 1:1000,发展中国家的年发病率为 2.1 至 130.7/百万,发达国家为 15 至 39/百万。据多学科数字出版研究所 (MDPI) 称,全球估计有 300 万人患有创伤性 SCI,每年报告约 180,000 个新病例。 SCI 通常会导致毁灭性的、长期的神经功能缺损,表现为损伤水平以下的运动、感觉或自主神经系统功能障碍。需要彻底修复或再生受损的组织或器官,恢复其功能。组织工程和再生医学(TERM)的出现似乎使这成为可能。组织工程结合细胞、支架和生长因子来再生组织或替换受损或患病的组织。相比之下,再生医学将组织工程与其他策略相结合,包括基于细胞的治疗、基因治疗和免疫调节,以诱导体内组织/器官再生。癌症是全世界死亡的主要原因之一,这种疾病影响着大量人口。因此,它给社会带来了巨大的经济负担。据世界卫生组织称,2018 年,全球约有 960 万人因癌症死亡。然而,越来越多的关于开发有效癌症治疗方法的研究推动了市场的增长。基因疗法和细胞疗法正在改变癌症治疗格局。例如,诺华 Kymriah 用于治疗弥漫性大 B 细胞淋巴瘤。此类产品的推出数量不断增加将推动对细胞和基因疗法的需求,预计这将在未来几年推动组织工程市场。

凭借新功能和技术,供应商可以吸引新的产品客户并扩大其在新兴市场的足迹。这一因素可能会推动欧洲组织工程市场在预测期内实现大幅复合年增长率。

欧洲组织工程市场收入和预测至 2028 年(百万美元)  

欧洲组织工程市场细分

欧洲组织工程市场根据材料类型、应用和国家/地区进行细分。根据材料类型,市场分为生物衍生材料、合成材料等。 2021年,生物衍生材料领域占据更大的市场份额;预计合成材料在预测期内将出现更高的复合年增长率。根据应用,市场分为骨科、肌肉骨骼和医疗领域。脊柱、皮肤和外皮、心脏病学和血管、神经病学、癌症、胃肠病学、妇科、泌尿科等。 2021 年,骨科、肌肉骨骼和脊柱细分市场占有最大的市场份额;和皮肤&预计在预测期内,外皮将达到市场上最高的复合年增长率。根据国家/地区,欧洲组织工程市场分为德国、英国、法国、意大利、西班牙和欧洲其他地区。 2021年,德国占据最大市场份额;预计在预测期内将以最快的复合年增长率增长。

Zimmer Biomet; B. 布劳恩梅尔松根股份公司;史赛克公司;艾伯维公司; Integra生命科学控股公司;器官发生公司;美敦力;百特国际公司;强生服务公司; 3M;和 Cook Biotech Inc. 是欧洲组织工程市场的领先公司之一。



Europe Tissue Engineering Strategic Insights

Strategic insights for Europe Tissue Engineering involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-tissue-engineering-market-strategic-framework.webp
Get more information on this report

Europe Tissue Engineering Report Scope

Report Attribute Details
Market size in 2021 US$ 3,859.49 Million
Market Size by 2028 US$ 8,520.70 Million
Global CAGR (2021 - 2028) 12.0%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 材料类型
  • 合成材料
  • 生物衍生材料
By 应用
  • 骨科
  • 肌肉骨骼及脊柱
  • 神经内科
  • 心脏病学及血管
  • 皮肤及体表
  • 泌尿科
  • 胃肠及妇科
  • 癌症
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Zimmer Biomet
  • B. Braun Melsungen AG
  • Stryker Corporation
  • AbbVie, Inc.
  • Integra LifeSciences Holdings Corporation
  • Organogenesis Inc.
  • Medtronic
  • Baxter International Inc.
  • Johnson and Johnson Services, Inc.
  • 3M
  • Get more information on this report

    Europe Tissue Engineering Regional Insights

    The regional scope of Europe Tissue Engineering refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-tissue-engineering-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Tissue Engineering Market

    1. Zimmer Biomet
    2. B. Braun Melsungen AG
    3. Stryker Corporation
    4. AbbVie, Inc.
    5. Integra LifeSciences Holdings Corporation      
    6. Organogenesis Inc.                                                    
    7. Medtronic
    8. Baxter International Inc.
    9. Johnson and Johnson Services, Inc.
    10. 3M
    11. Cook Biotech Inc.
    Frequently Asked Questions
    How big is the Europe Tissue Engineering Market?

    The Europe Tissue Engineering Market is valued at US$ 3,859.49 Million in 2021, it is projected to reach US$ 8,520.70 Million by 2028.

    What is the CAGR for Europe Tissue Engineering Market by (2021 - 2028)?

    As per our report Europe Tissue Engineering Market, the market size is valued at US$ 3,859.49 Million in 2021, projecting it to reach US$ 8,520.70 Million by 2028. This translates to a CAGR of approximately 12.0% during the forecast period.

    What segments are covered in this report?

    The Europe Tissue Engineering Market report typically cover these key segments-

  • 材料类型 (合成材料, 生物衍生材料)
  • 应用 (骨科, 肌肉骨骼及脊柱, 神经内科, 心脏病学及血管, 皮肤及体表, 泌尿科, 胃肠及妇科, 癌症)
  • What is the historic period, base year, and forecast period taken for Europe Tissue Engineering Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Tissue Engineering Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Europe Tissue Engineering Market?

    The Europe Tissue Engineering Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Zimmer Biomet
  • B. Braun Melsungen AG
  • Stryker Corporation
  • AbbVie, Inc.
  • Integra LifeSciences Holdings Corporation
  • Organogenesis Inc.
  • Medtronic
  • Baxter International Inc.
  • Johnson and Johnson Services, Inc.
  • 3M
  • Cook Biotech Inc.
  • Who should buy this report?

    The Europe Tissue Engineering Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Tissue Engineering Market value chain can benefit from the information contained in a comprehensive market report.